PDCD1 and Merkel cell skin cancer: Thus, Wong et al. reported in 2020 that in the peripheral blood of MCC patients, circulating CD8+ T cells reactive to MCPyV T antigen (T-Ag) were subjected to anti-PD-1 immunotherapy [187].